What caused the large move in ZLD.AX stock today?

The rally was driven by heavy volume and thin float dynamics rather than a single disclosed corporate event. Volume reached **1,024,288** against an average of **15,817**, amplifying price moves. Check ASX filings and Zelira announcements for any after-hours confirmation.

How does the Meyka AI grade affect ZLD.AX stock view?

Meyka AI rates ZLD.AX with a score out of 100: **64.99 | Grade B | HOLD**. The grade balances sector comparisons, growth metrics and forecasts. It flags opportunity but notes material financial weakness. Grades are informational, not investment advice.

What short-term levels should traders monitor for ZLD.AX stock?

Monitor support near **A$0.50**, intraday pivot at **A$0.86**, and resistance around **A$1.20–A$1.30**. Use tight stops given historical liquidity and volatility. Confirm news flow before adding exposure.

What are the Meyka AI forecast figures for ZLD.AX stock?

Meyka AI’s forecast model projects a monthly price of **A$0.22** and a quarterly price of **A$0.12** versus the current close **A$0.905**. Forecasts are model-based projections and not guarantees.

AU Stocks

ZLD.AX stock up 151% on heavy volume (ASX 19 Jan 2026): what traders watch

ByHuzaifa Zahoor January 19, 2026January 19, 2026

ZLD.AX stock led today’s high-volume movers after jumping 151.39% to A$0.905 on the ASX at market close on 19 Jan 2026. Volume surged to 1,024,288 shares versus an average of 15,817, giving a relative volume of 50.63. We track this move as a classic liquidity-driven breakout where price, volume and short-term technical signals align. Zelira Therapeutics Limited (ZLD.AX) trades on the ASX in Australia and closed with a day range of A$0.86–A$1.15. Below we break down the drivers, fundamentals, technicals, risks and a concise Meyka AI view for traders and investors.